Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1996-10-04
1998-12-08
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
A61K 5104
Patent
active
058465146
ABSTRACT:
A method of enhancing the efficiency and increasing the duration of action of drugs (e.g. dihydropyridines and anti-bacterials) and particularly of nifedipine and penicillins wherein one or more hydrogen atoms are deuterated and wherein the deuterated drug has unexpectedly improved properties when used in much lower concentrations than unmodified drug. A method for determining the identity and bioequivalency of a new drug is also disclosed wherein the molecular and isotope structure of a new drug is determined by isotope ratio mass spectrometry and compared with the molecular and isotope structure of a known human drug.
REFERENCES:
patent: 3314827 (1967-04-01), de Vries
patent: 4304782 (1981-12-01), Dumont et al.
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4636509 (1987-01-01), Phillipps et al.
patent: 4675338 (1987-06-01), Bommer et al.
patent: 4874780 (1989-10-01), Borretzen et al.
patent: 4898855 (1990-02-01), Baggiolini et al.
patent: 5012052 (1991-04-01), Hayes
patent: 5049396 (1991-09-01), Oftebro et al.
patent: 5122511 (1992-06-01), Patchette et al.
patent: 5130145 (1992-07-01), Oftebro et al.
patent: 5149820 (1992-09-01), Borretzen et al.
patent: 5149846 (1992-09-01), Baggiolini et al.
patent: 5169773 (1992-12-01), Rosenthaler et al.
patent: 5227467 (1993-07-01), Durette et al.
patent: 5247123 (1993-09-01), Baggiolini et al.
patent: 5314827 (1994-05-01), Schmidt
patent: 5318901 (1994-06-01), Patchett et al.
patent: 5376540 (1994-12-01), Kyle
patent: 5424539 (1995-06-01), Brand et al.
patent: 5432058 (1995-07-01), Lange et al.
patent: 5525590 (1996-06-01), Bollinger et al.
patent: 5604254 (1997-02-01), Quadro
Rampe, D., et al., "Deuterated analogs of verapamil and nifedipine", European Journal of Medicinal Chemistry (1993), vol. 28, pp. 259-263.
Chemical Abstracts Tenth Collective Index, 1982, p. 46167cs.
Chemical Abstracts Eleventh Collective Index, 1987, pp. 58923cs.
Chemical Abstracts Twelfth Collective Index, 1992, p. 79669cs. vivo studies of dihydropyridine binding in man using positron emission tomography", International Journal of Radiation Applications and Instrumentation Part A: Applied Radiation and isotopes (1991), vol. 42, pp. 871-875.
Funaki et al., "In Vivo Oxidative Cleavage of a Pyridine-Carboxylic Acid Ester Metabolitic of Nifedipine," Biochemical Pharmacolgy, vol. 38, No. 23, pp. 4213-4216, 1989.
Caille Gilles
Foster Robert T.
Lewanczuk Richard
Hartley Michael G.
Hollinden Gary E.
Isotechnika Inc.
LandOfFree
Enhancement of the efficacy of nifedipine by deuteration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of the efficacy of nifedipine by deuteration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of the efficacy of nifedipine by deuteration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-174342